Focus
Blinded Microdose Trial Design
Blinded microdose trial design randomizes active versus placebo arms with pre-registered outcomes—literacy maps headlines to endpoints, not influencer summaries.
Blinded microdose trial design randomizes participants to active microdoses or placebos while masking allocation—ideally with independent raters and pre-registered outcomes like mood scales or cognitive batteries. Designs note washout periods, contraindicated medications, and psychiatric screening.
Partial blinding breaks when cues leak. Educational literacy maps headline claims to primary endpoints, not influencer summaries.
Common questions
-
What makes a microdosing trial credible?
Pre-registration, placebo control, adequate N, validated scales, safety monitoring, and transparent null results. Single-arm anecdotes without blinding are hypothesis-generating only.
Related terms
Put Blinded Microdose Trial Design into practice
Ohga connects nutrition, fitness, focus, and habits with an AI copilot that learns your patterns. Join the waitlist for early access.